Chapter

Neo-adjuvant and adjuvant hormone therapy for high-risk localized prostate cancer

Mike D Shelley and Malcolm D Mason

in Systemic Treatment of Prostate Cancer

Published on behalf of Oxford University Press

ISBN: 9780199561421
Published online May 2011 | e-ISBN: 9780199607372 | DOI: http://dx.doi.org/10.1093/med/9780199561421.003.0003

Series: Oxford Oncology Library

Neo-adjuvant and adjuvant hormone therapy for high-risk localized prostate cancer

Show Summary Details

Preview

• Neo-adjuvant or adjuvant hormone therapy enhances the effectiveness of radiotherapy and significantly improves outcomes, including overall survival • Neo-adjuvant hormone therapy, prior to radical prostatectomy improves pathological variables but not important clinical outcomes • The role of adjuvant hormone therapy following radical prostatectomy in high risk patients has not yet been established.

Chapter.  3622 words. 

Subjects: Clinical Oncology

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.